4//SEC Filing
White William Richard 4
Accession 0000950170-25-093319
CIK 0001744659other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 6:00 PM ET
Size
5.1 KB
Accession
0000950170-25-093319
Insider Transaction Report
Form 4
White William Richard
Chief Financial Officer
Transactions
- Award
Common Stock
2025-06-30$23.87/sh+890$21,243→ 58,411 total
Footnotes (2)
- [F1]Mr. White is voluntarily reporting the acquisition of these shares on June 30, 2025 pursuant to the Akero Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(c) and Rule 16b-3(d).
- [F2]In accordance with the provisions of the Akero Therapeutics, Inc. 2019 Employee Stock Purchase Plan, these shares were purchased at 85% of the closing price of the Issuer's common stock on January 2, 2025.
Documents
Issuer
Akero Therapeutics, Inc.
CIK 0001744659
Entity typeother
Related Parties
1- filerCIK 0001778739
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 6:00 PM ET
- Size
- 5.1 KB